Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
Abstract. The incidence of pancreatic cancer has been rising worldwide, and its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Association, the Chinese...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2021-06-01
|
Series: | Journal of Pancreatology |
Online Access: | http://journals.lww.com/10.1097/JP9.0000000000000072 |
id |
doaj-f38efe30264744cca70be1d7add4e385 |
---|---|
record_format |
Article |
spelling |
doaj-f38efe30264744cca70be1d7add4e3852021-09-22T02:59:46ZengWolters Kluwer Health/LWWJournal of Pancreatology2096-56642577-35772021-06-0142496610.1097/JP9.0000000000000072202106000-00001Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)Yinmo YangXueli BaiDapeng BianShouwang CaiRufu ChenFeng CaoMenghua DaiChihua FangDeliang FuChunlin GeXiaochao GuoChunyi HaoJihui HaoHeguang HuangZhixiang JianGang JinFei LiHaimin LiShengping LiWeiqin LiYixiong LiHongzhen LiTingbo LiangXubao LiuWenhui LouYi MiaoYiping MouChenghong PengRenyi QinChenghao ShaoBei SunGuang TanXiaodong TianHuaizhi WangLei WangWei WangWeilin WangJunmin WeiHeshui WuWenming WuZheng WuJingyong XuChangqing YanXiaoyu YinXianjun YuChunhui YuanTaiping ZhangJixin ZhangJun ZhouYupei Zhaoon behalf of the Chinese Pancreatic Surgery AssociationAbstract. The incidence of pancreatic cancer has been rising worldwide, and its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Association, the Chinese Society of Surgery, Chinese Medical Association revised the Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China (2014) after reviewing evidence-based and problem-oriented literature published during 2015–2021, mainly focusing on highlight issues regarding diagnosis and surgical treatment of pancreatic cancer, conversion strategies for locally advanced pancreatic cancer, treatment of pancreatic cancer with oligo metastasis, adjuvant and neoadjuvant therapy, standardized processing of surgical specimens and evaluation of surgical margin status, systemic treatment for unresectable pancreatic cancer, genetic testing, as well as postoperative follow up of patients with pancreatic cancer. Forty recommendation items were finally proposed based on the above issues, and the quality of evidence and strength of recommendations were graded using the Grades of Recommendation, Assessment, Development, and Evaluation system. This guideline aims to standardize the clinical diagnosis and therapy, especially surgical treatment of pancreatic cancer in China, and further improve the prognosis of patients with pancreatic cancer.http://journals.lww.com/10.1097/JP9.0000000000000072 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yinmo Yang Xueli Bai Dapeng Bian Shouwang Cai Rufu Chen Feng Cao Menghua Dai Chihua Fang Deliang Fu Chunlin Ge Xiaochao Guo Chunyi Hao Jihui Hao Heguang Huang Zhixiang Jian Gang Jin Fei Li Haimin Li Shengping Li Weiqin Li Yixiong Li Hongzhen Li Tingbo Liang Xubao Liu Wenhui Lou Yi Miao Yiping Mou Chenghong Peng Renyi Qin Chenghao Shao Bei Sun Guang Tan Xiaodong Tian Huaizhi Wang Lei Wang Wei Wang Weilin Wang Junmin Wei Heshui Wu Wenming Wu Zheng Wu Jingyong Xu Changqing Yan Xiaoyu Yin Xianjun Yu Chunhui Yuan Taiping Zhang Jixin Zhang Jun Zhou Yupei Zhao on behalf of the Chinese Pancreatic Surgery Association |
spellingShingle |
Yinmo Yang Xueli Bai Dapeng Bian Shouwang Cai Rufu Chen Feng Cao Menghua Dai Chihua Fang Deliang Fu Chunlin Ge Xiaochao Guo Chunyi Hao Jihui Hao Heguang Huang Zhixiang Jian Gang Jin Fei Li Haimin Li Shengping Li Weiqin Li Yixiong Li Hongzhen Li Tingbo Liang Xubao Liu Wenhui Lou Yi Miao Yiping Mou Chenghong Peng Renyi Qin Chenghao Shao Bei Sun Guang Tan Xiaodong Tian Huaizhi Wang Lei Wang Wei Wang Weilin Wang Junmin Wei Heshui Wu Wenming Wu Zheng Wu Jingyong Xu Changqing Yan Xiaoyu Yin Xianjun Yu Chunhui Yuan Taiping Zhang Jixin Zhang Jun Zhou Yupei Zhao on behalf of the Chinese Pancreatic Surgery Association Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) Journal of Pancreatology |
author_facet |
Yinmo Yang Xueli Bai Dapeng Bian Shouwang Cai Rufu Chen Feng Cao Menghua Dai Chihua Fang Deliang Fu Chunlin Ge Xiaochao Guo Chunyi Hao Jihui Hao Heguang Huang Zhixiang Jian Gang Jin Fei Li Haimin Li Shengping Li Weiqin Li Yixiong Li Hongzhen Li Tingbo Liang Xubao Liu Wenhui Lou Yi Miao Yiping Mou Chenghong Peng Renyi Qin Chenghao Shao Bei Sun Guang Tan Xiaodong Tian Huaizhi Wang Lei Wang Wei Wang Weilin Wang Junmin Wei Heshui Wu Wenming Wu Zheng Wu Jingyong Xu Changqing Yan Xiaoyu Yin Xianjun Yu Chunhui Yuan Taiping Zhang Jixin Zhang Jun Zhou Yupei Zhao on behalf of the Chinese Pancreatic Surgery Association |
author_sort |
Yinmo Yang |
title |
Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) |
title_short |
Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) |
title_full |
Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) |
title_fullStr |
Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) |
title_full_unstemmed |
Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) |
title_sort |
guidelines for the diagnosis and treatment of pancreatic cancer in china (2021) |
publisher |
Wolters Kluwer Health/LWW |
series |
Journal of Pancreatology |
issn |
2096-5664 2577-3577 |
publishDate |
2021-06-01 |
description |
Abstract. The incidence of pancreatic cancer has been rising worldwide, and its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Association, the Chinese Society of Surgery, Chinese Medical Association revised the Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China (2014) after reviewing evidence-based and problem-oriented literature published during 2015–2021, mainly focusing on highlight issues regarding diagnosis and surgical treatment of pancreatic cancer, conversion strategies for locally advanced pancreatic cancer, treatment of pancreatic cancer with oligo metastasis, adjuvant and neoadjuvant therapy, standardized processing of surgical specimens and evaluation of surgical margin status, systemic treatment for unresectable pancreatic cancer, genetic testing, as well as postoperative follow up of patients with pancreatic cancer. Forty recommendation items were finally proposed based on the above issues, and the quality of evidence and strength of recommendations were graded using the Grades of Recommendation, Assessment, Development, and Evaluation system. This guideline aims to standardize the clinical diagnosis and therapy, especially surgical treatment of pancreatic cancer in China, and further improve the prognosis of patients with pancreatic cancer. |
url |
http://journals.lww.com/10.1097/JP9.0000000000000072 |
work_keys_str_mv |
AT yinmoyang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT xuelibai guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT dapengbian guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT shouwangcai guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT rufuchen guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT fengcao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT menghuadai guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT chihuafang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT deliangfu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT chunlinge guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT xiaochaoguo guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT chunyihao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT jihuihao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT heguanghuang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT zhixiangjian guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT gangjin guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT feili guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT haiminli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT shengpingli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT weiqinli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT yixiongli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT hongzhenli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT tingboliang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT xubaoliu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT wenhuilou guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT yimiao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT yipingmou guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT chenghongpeng guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT renyiqin guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT chenghaoshao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT beisun guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT guangtan guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT xiaodongtian guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT huaizhiwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT leiwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT weiwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT weilinwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT junminwei guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT heshuiwu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT wenmingwu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT zhengwu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT jingyongxu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT changqingyan guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT xiaoyuyin guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT xianjunyu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT chunhuiyuan guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT taipingzhang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT jixinzhang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT junzhou guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT yupeizhao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 AT onbehalfofthechinesepancreaticsurgeryassociation guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021 |
_version_ |
1717371977160720384 |